Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report

Transplant Proc. 2018 Apr;50(3):910-914. doi: 10.1016/j.transproceed.2018.02.013.

Abstract

Background: Although active tuberculosis (TB) is considered a contraindication for liver transplantation (LT), this is the only treatment in patients with liver failure and concurrent active TB. We report a case with successful urgent living-donor LT for irreversible liver failure in the presence of active TB.

Case presentation: A 48-year-old man, with a history of decompensated alcoholic liver cirrhosis, was presented with stupor. At admission, his consciousness had deteriorated to semi-coma, and his renal function also rapidly deteriorated to hepatorenal syndrome. A preoperative computed tomography scan of the chest revealed several small cavitary lesions in both upper lobes, and acid-fast bacillus stain from his sputum was graded 2+. Adenosine deaminase levels from ascites were elevated, suggesting TB peritonitis. A first-line anti-TB drug regimen was started immediately (rifampin, isoniazid, levofloxacin, and amikacin). An urgent living-donor LT was performed 2 days later. After LT, the regimen was changed to second-line anti-TB drugs (amikacin, levofloxacin, cycloserine, and pyridoxine). The sputum acid-fast bacillus stain tested negative on postoperative day 10. His liver function remained well preserved, even after the reversion to first-line anti-TB treatment. The patient recovered without any anti-TB medication-related complications and was discharged.

Conclusions: LT can be prudently performed as a life-saving option, particularly for patients with liver failure and concurrent active TB.

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Isoniazid / therapeutic use
  • Levofloxacin / therapeutic use
  • Liver Failure / complications*
  • Liver Transplantation*
  • Living Donors
  • Male
  • Middle Aged
  • Rifampin / therapeutic use
  • Tuberculosis / complications*
  • Tuberculosis / drug therapy

Substances

  • Antitubercular Agents
  • Levofloxacin
  • Isoniazid
  • Rifampin